Recall: Apotex Corporation Piperacillin And Tazobactam For Injection
On 2018-05-14, the FDA announced that Apotex is conducting a recall on Piperacillin And Tazobactam For Injection due to a possible elevated impurity . The recalled products were sold under the brand name(s) Apotex Corporation during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 2 drugs recalls due to potential elevated impurity , including methylprednisolone sodium succinate for injection, usp 40mg, 125mg, and 1g, homeopathic products and more. Additionally, there have been 28 drug and medical device recalls due to other health hazards as well as 91 food recalls.
Company Contact Information:
Phone: 1- 877-319-8966
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Piperacillin and Tazobactam for Injection
Brand Name(s): Apotex Corporation
Reason for Recall: Elevated level of impurities
Official Recall Date: 2018-05-14
Additional information provided by the FDA.gov:
Apotex Corp. is voluntarily recalling 36 lots of Piperacillin and Tazobactam for Injection, USP 3.375 gram/vial and 4.5 gram/vial strengths, to the consumer/user level. The Piperacillin and Tazobactam for Injection have been found to contain elevated levels of impurities that may result in decreased potency. The affected product is manufactured by Hospira Inc., a Pfizer Company and distributed in the US market by Apotex Corp. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.